These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26657848)

  • 21. Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma.
    Chang X; Zhu Y; Shi C; Stewart AK
    Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):240-53. PubMed ID: 24374776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity.
    Gandhi AK; Mendy D; Waldman M; Chen G; Rychak E; Miller K; Gaidarova S; Ren Y; Wang M; Breider M; Carmel G; Mahmoudi A; Jackson P; Abbasian M; Cathers BE; Schafer PH; Daniel TO; Lopez-Girona A; Thakurta A; Chopra R
    Br J Haematol; 2014 Jan; 164(2):233-44. PubMed ID: 24206017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance.
    Davis LN; Walker ZJ; Reiman LT; Parzych SE; Stevens BM; Jordan CT; Forsberg PA; Sherbenou DW
    Clin Cancer Res; 2024 Jul; 30(14):3023-3035. PubMed ID: 38723281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Old and new generation immunomodulatory drugs in multiple myeloma.
    Derudas D; Capraro F; Martinelli G; Cerchione C
    Panminerva Med; 2020 Dec; 62(4):207-219. PubMed ID: 32955182
    [TBL] [